Description
This book provides the latest research and developments in the field of metronomic chemotherapy for breast cancer. It presents the principles and mechanisms of metronomic chemotherapy, preclinical and clinical studies, and the latest developments in drug delivery systems and nanoformulations. The clinical pharmacology of metronomic chemotherapy, including pharmacokinetics, pharmacogenetics, pharmacoeconomics, and adverse drug reactions, are also examined.
Key Features:
- Introduces metronomics therapy in the neoadjuvant and adjuvant treatment of breast cancer
- Explores the potential of metronomics in terms of personalized chemotherapy
- Present pharmacological bases of metronomic chemotherapy
- Covers the latest developments in drug delivery systems, nanotechnology, and nanoformulations
- Discusses antiangiogenic effects and the impact of metronomics on immunity
This book is useful for students, researchers, oncologists, pharmacologists, and healthcare experts interested in understanding the clinical potential of metronomic chemotherapy in breast cancer.
Table of Contents
Chapter 1 Introduction to metronomic chemotherapy
Chapter 2 Metronomic chemotherapy- a multi-targeted therapy
Chapter 3 Conventional chemotherapeutic vs. metronomic chemotherapy
Chapter 4 The anti-angiogenic basis of metronomic chemotherapy
Chapter 5 Imaging techniques, biomarkers, and methods for metronomic chemotherapy
Chapter 6 Metronomic chemotherapy in breast cancer
Chapter 7 Metronomic chemotherapy in combination with anticancer vaccines
Chapter 8 Metronomic: towards personalized chemotherapy
Chapter 9 Metronomic chemotherapy for metastatic breast cancer
Chapter 10 Recent Advances, challenges, and future of metronomic chemotherapy
Chapter 11 Targeted therapies in combination with metronomic chemotherapy
Chapter 12 Recent advances in metronomic chemotherapy: nanotechnology-based low-dose chemotherapy in breast cancer
Index
